AstraZeneca
From the wire
Original publisher articles citing AstraZeneca. Broadside has not yet written editorial coverage for these.
FDA Approves AstraZeneca Drug With New Approach to Lowering High Blood Pressure
FDA approves AstraZeneca’s new kind of hypertension drug
Why Real-World Evidence Is Becoming the Missing Link Between Innovation and Patient Care in Oncology
Degron, CREATE, TenNor raise capital; Cabaletta posts CAR-T data
The health benefits of saunas: backed by research and experts
Regeneron reaches $125M Parabilis deal for hard-to-catch drug targets
Abeona pivots to T cells; AstraZeneca's rare disease drug passes Phase 3